ADT: clinical trials recruiting now
9
Recruiting trials
11
Conditions studied
40
US states with sites
6
Countries
Phase breakdown
Phase 1 2
Phase 2 6
Phase 3 2
Not applicable 1
Conditions being studied
Recruiting trials involving ADT
- A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
- A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
- An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
- Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
- Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
- Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)
- Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
Common questions
How many recruiting trials involve ADT?
9 recruiting trials across 11 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.